BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18222232)

  • 21. Glomeruloid microvascular proliferation is superior to intratumoral microvessel density as a prognostic marker in non-small cell lung cancer.
    Tanaka F; Oyanagi H; Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
    Cancer Res; 2003 Oct; 63(20):6791-4. PubMed ID: 14583475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
    Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
    Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.
    Massabeau C; Rouquette I; Lauwers-Cances V; Mazières J; Bachaud JM; Armand JP; Delisle MB; Favre G; Toulas C; Cohen-Jonathan-Moyal E
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):696-702. PubMed ID: 19386436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Gatter KC; Harris AL
    J Pathol; 2000 Oct; 192(2):140-9. PubMed ID: 11004689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients.
    Kadota K; Huang CL; Liu D; Ueno M; Kushida Y; Haba R; Yokomise H
    Eur J Cancer; 2008 May; 44(7):1057-67. PubMed ID: 18396396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
    Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
    Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
    J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of thymosin beta10 and its role in non-small cell lung cancer.
    Gu Y; Wang C; Wang Y; Qiu X; Wang E
    Hum Pathol; 2009 Jan; 40(1):117-24. PubMed ID: 18789485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer.
    Takenaka K; Ogawa E; Oyanagi H; Wada H; Tanaka F
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1972-5. PubMed ID: 16103446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
    Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
    Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.
    Saintigny P; Besse B; Callard P; Vergnaud AC; Czernichow S; Colombat M; Girard P; Validire P; Breau JL; Bernaudin JF; Soria JC
    Clin Cancer Res; 2007 Aug; 13(16):4825-31. PubMed ID: 17699861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice.
    Hast J; Schiffer IB; Neugebauer B; Teichman E; Schreiber W; Brieger J; Kim DW; Gebhard S; Born CJ; Strugala M; Sagemüller J; Brenner W; Mann WJ; Oesch F; Thelen M; Hengstler JG
    Anticancer Res; 2002; 22(2A):677-88. PubMed ID: 12014637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.
    Sun Z; Aubry MC; Deschamps C; Marks RS; Okuno SH; Williams BA; Sugimura H; Pankratz VS; Yang P
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1014-20. PubMed ID: 16678584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol abuse predicts progression of disease and death in patients with lung cancer.
    Paull DE; Updyke GM; Baumann MA; Chin HW; Little AG; Adebonojo SA
    Ann Thorac Surg; 2005 Sep; 80(3):1033-9. PubMed ID: 16122481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer.
    Chen KY; Lee LN; Yu CJ; Lee YC; Kuo SH; Yang PC
    Cancer Lett; 2006 Aug; 240(1):148-56. PubMed ID: 16249053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer.
    Liu D; Nakano J; Ishikawa S; Yokomise H; Ueno M; Kadota K; Urushihara M; Huang CL
    Lung Cancer; 2007 Dec; 58(3):384-91. PubMed ID: 17728005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.